Insulin Glargine and Lixisenatide (Soliqua 100/33)
Questions a plan sponsor actually asks.
What is Insulin Glargine and Lixisenatide used for?
Insulin Glargine and Lixisenatide is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Insulin Glargine and Lixisenatide?
No. Insulin Glargine and Lixisenatide is brand-only with no generic equivalents currently in market.
How much does my plan pay for Insulin Glargine and Lixisenatide?
Across 329 Part D plans, Insulin Glargine and Lixisenatide averages $57.06/unit (NADAC). Lowest available: $57.06/unit. Highest in distribution: $57.06/unit.
Is Insulin Glargine and Lixisenatide on the FDA shortage list?
No. Insulin Glargine and Lixisenatide is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (1 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.